10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001493152-20-021121`
Period End Date	20200930
Filing Date	20201112
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	aim-20200930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 68 Cash Flow Statement 80 Stockholders Equity 26

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.50M	USD	Point-in-time
Marketable securities, short term	`AvailableForSaleSecuritiesCurrent`	$1.14M	USD	Point-in-time
Marketable securities, short term	`AvailableForSaleSecuritiesCurrent`	$7.31M	USD	Point-in-time
Funds receivable from sale of New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$776.00K	USD	Point-in-time
Funds receivable from sale of New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$44.00K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$26.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$848.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$91.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$39.76M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.45M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.63M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.12M	USD	Point-in-time
Right of use assets, net	`OperatingLeaseRightOfUseAsset`	$188.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Right of use assets, net	`OperatingLeaseRightOfUseAsset`	$152.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.41M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.15M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Marketable securities, long term	`AvailableForSaleSecuritiesNoncurrent`	$14.84M	USD	Point-in-time
Marketable securities, long term	`AvailableForSaleSecuritiesNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.69M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.39M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.35M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.69M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.39M	shares	Point-in-time
Total assets	`Assets`	$20.22M	USD	Point-in-time
Total assets	`Assets`	$64.16M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$205.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$472.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$322.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$403.00K	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$38.00K	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$42.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$226.00K	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$214.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$795.00K	USD	Point-in-time
Operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$114.00K	USD	Point-in-time
Operating lease obligation	`OperatingLeaseLiabilityNoncurrent`	$146.00K	USD	Point-in-time
Notes payable, net	`LongTermNotesPayable`	$3.91M	USD	Point-in-time
Notes payable, net	`LongTermNotesPayable`	-	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 14)	`LongTermDebtNoncurrent`	$1.93M	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 14)	`LongTermDebtNoncurrent`	$2.10M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$177.00K	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$57.00K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 8,000 shares designated, 733 and 778 shares issues and outstanding, respectively	`PreferredStockValue`	$778.00K	USD	Point-in-time
Series B Convertible Preferred Stock, stated value $1,000 per share, 8,000 shares designated, 733 and 778 shares issues and outstanding, respectively	`PreferredStockValue`	$733.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 40,685,282 and 10,386,754 respectively	`CommonStockValue`	$41.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 40,685,282 and 10,386,754 respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$398.93M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$340.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-12.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-338.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-328.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$13.84M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$61.11M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$20.22M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$64.16M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$90.00K	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$61.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$36.00K	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$121.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$230.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$676.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$608.00K	USD	3 Qtrs
Production costs	`ManufacturingCosts`	$204.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.44M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.21M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.08M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.55M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.85M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.07M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$9.45M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.27M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$10.12M	USD	3 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.39M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.36M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.21M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-10.00M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.35M	USD	1 Quarter
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$8.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$131.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$44.00K	USD	3 Qtrs
Interest and other income	`InterestAndOtherNonOperatingIncomeExpense`	$69.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	$193.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	$617.00K	USD	3 Qtrs
Interest expense and other finance costs	`InterestAndDebtExpense`	$51.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestAndDebtExpense`	$537.00K	USD	3 Qtrs
Extinguishment of notes payable	`ExtinguishmentsOfNotesPayable`	-	USD	1 Quarter
Extinguishment of notes payable	`ExtinguishmentsOfNotesPayable`	$-250.00K	USD	3 Qtrs
Extinguishment of notes payable	`ExtinguishmentsOfNotesPayable`	$142.00K	USD	3 Qtrs
Extinguishment of notes payable	`ExtinguishmentsOfNotesPayable`	-	USD	1 Quarter
Convertible note valuation adjustment	`ConvertibleNoteValuationAdjustment`	$4.00K	USD	1 Quarter
Convertible note valuation adjustment	`ConvertibleNoteValuationAdjustment`	-	USD	3 Qtrs
Convertible note valuation adjustment	`ConvertibleNoteValuationAdjustment`	-	USD	1 Quarter
Convertible note valuation adjustment	`ConvertibleNoteValuationAdjustment`	$-12.00K	USD	3 Qtrs
Settlement of litigation	`LitigationSettlementExpense`	-	USD	3 Qtrs
Settlement of litigation	`LitigationSettlementExpense`	$-260.00K	USD	3 Qtrs
Settlement of litigation	`LitigationSettlementExpense`	-	USD	1 Quarter
Settlement of litigation	`LitigationSettlementExpense`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-446.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$120.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-31.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.49M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.34M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.47M	USD	3 Qtrs
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-75.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-12.00K	USD	3 Qtrs
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.38M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.34M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.48M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.95M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-4.41	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.36	USD	3 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-1.13	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.60M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.83M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	38.91M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.89M	shares	3 Qtrs

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.34M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-3.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-10.47M	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$500.00K	USD	3 Qtrs
Depreciation of property and equipment	`Depreciation`	$557.00K	USD	3 Qtrs
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$-1.49M	USD	3 Qtrs
Redeemable warrants valuation adjustment	`RedeemableWarrantsValuationAdjustment`	$120.00K	USD	3 Qtrs
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustments`	-	USD	3 Qtrs
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustments`	$-12.00K	USD	3 Qtrs
Change in convertible debt - refinancing	`ChangeInConvertibleDebtRefinancing`	$20.00K	USD	3 Qtrs
Change in convertible debt - refinancing	`ChangeInConvertibleDebtRefinancing`	-	USD	3 Qtrs
Extinguishment of notes payable	`ExtinguishmentOfNotesPayable`	$345.00K	USD	3 Qtrs
Extinguishment of notes payable	`ExtinguishmentOfNotesPayable`	$142.00K	USD	3 Qtrs
Warrant modification	`WarrantModification`	-	USD	3 Qtrs
Warrant modification	`WarrantModification`	$46.00K	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$53.00K	USD	3 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$41.00K	USD	3 Qtrs
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$26.00K	USD	3 Qtrs
Changes in ROU assets	`IncreaseDecreaseinRightofUseAssets`	$-36.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$649.00K	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$596.00K	USD	3 Qtrs
Realized (loss) gain on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$12.00K	USD	3 Qtrs
Realized (loss) gain on sale of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	3 Qtrs
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$77.00K	USD	3 Qtrs
Amortization of finance and debt issuance costs	`AmortizationOfFinancingCosts`	$303.00K	USD	3 Qtrs
Accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-1.03M	USD	3 Qtrs
Accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-794.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-764.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-49.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$25.00K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$-36.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-265.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$24.00K	USD	3 Qtrs
Accrued interest expense	`IncreaseDecreaseInAccruedInterestExpense`	-	USD	3 Qtrs
Accrued interest expense	`IncreaseDecreaseInAccruedInterestExpense`	$230.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-81.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$27.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.78M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.51M	USD	3 Qtrs
Proceeds from sale of marketable securities	`PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm`	-	USD	3 Qtrs
Proceeds from sale of marketable securities	`PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm`	$-8.50M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$588.00K	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$17.17M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$68.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$297.00K	USD	3 Qtrs
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$202.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.98M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-858.00K	USD	3 Qtrs
Payment of note payable	`RepaymentsOfNotesPayable`	$4.28M	USD	3 Qtrs
Payment of note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Financing obligation payments	`RepaymentsOfLongTermDebt`	$254.00K	USD	3 Qtrs
Financing obligation payments	`RepaymentsOfLongTermDebt`	$265.00K	USD	3 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$1.90M	USD	3 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$15.31M	USD	3 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$58.07M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$53.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.95M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$37.03M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.32M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$38.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$299.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.47M	USD	Point-in-time
Unrealized loss on marketable securities	`UnrealizedGainLossOnSecurities`	-	USD	3 Qtrs
Unrealized loss on marketable securities	`UnrealizedGainLossOnSecurities`	$-12.00K	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$4.53M	USD	3 Qtrs
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$45.00K	USD	3 Qtrs
Conversion of note payable into shares	`ConversionOfNotePayableIntoShares`	-	USD	3 Qtrs
Conversion of note payable into shares	`ConversionOfNotePayableIntoShares`	$1.47M	USD	3 Qtrs
Stock issued to settle accounts payable	`StockIssued1`	$20.00K	USD	3 Qtrs
Stock issued to settle accounts payable	`StockIssued1`	$84.00K	USD	3 Qtrs
Operating lease - right of use assets	`OperatingLeaseRightOfUseAssets`	$188.00K	USD	3 Qtrs
Operating lease - right of use assets	`OperatingLeaseRightOfUseAssets`	$65.00K	USD	3 Qtrs

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$61.11M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$16.94M	USD	3 Qtrs
Shares issued for: Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$58.07M	USD	3 Qtrs
Shares issued for: Convertible note originations shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.47M	USD	3 Qtrs
Deemed dividends	`Dividends`	$135.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$596.00K	USD	3 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$649.00K	USD	3 Qtrs
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.79M	USD	3 Qtrs
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$20.00K	USD	3 Qtrs
Shares issued to pay accounts payable	`SharesIssuedToPayAccountsPayable`	$84.00K	USD	3 Qtrs
Series B preferred shares issued, net of offering costs	`PreferredSharesIssuedNetOfOfferingCosts`	$5.31M	USD	3 Qtrs
Series B preferred shares converted to common shares	`ConversionOfStockAmountConverted1`	$4.53M	USD	3 Qtrs
Series B preferred shares converted to common shares	`ConversionOfStockAmountConverted1`	$45.00K	USD	3 Qtrs
Warrant modification	`WarrantModification`	-	USD	3 Qtrs
Warrant modification	`WarrantModification`	$46.00K	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.38M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.34M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-10.48M	USD	3 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.95M	USD	1 Quarter
Balance	`StockholdersEquity`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquity`	$13.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$61.11M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.